Abstract:Lung adenocarcinoma (LUAD) is one of the most lethal and common malignancies. The energy metabolism of LUAD is a critical factor affecting its malignant progression, and research on this topic can aid in the development of novel cancer treatment targets. Bioinformatics analysis of the expression of long non-coding RNA (lncRNA) LINC00665 in LUAD was performed. Downstream regulatory molecules of LINC00665 were predicted using the StarBase database. We used quantitative reverse transcription polymerase chain reaction and western blot to measure the expression at mRNA and protein levels, respectively. The effects of the LINC00665/let-7c-5p/HMMR axis on cell viability in vitro were tested by CCK-8 assay. The regulatory effects on glycolysis were analyzed by extracellular acidification rate, oxygen consumption rate, glucose uptake, adenosine triphosphate production, and lactate production. The predicted competitive endogenous RNA mechanism between LINC00665 and let-7c-5p/HMMR was verified by a dual-luciferase reporter gene assay. LINC00665 was upregulated in LUAD. Silencing LINC00665 inhibited tumor proliferation and reduced the glycolytic activity of tumor cells. Additionally, the expression of LINC00665 had a negative correlation with that of let-7c-5p, while the expression of HMMR was remarkably inhibited by let-7c-5p. HMMR could affect the development of LUAD by influencing glycolytic capacity. Mechanistically, LINC00665 acted as a molecular sponge to absorb let-7c-5p and targeted HMMR. Transfection of let-7c-5p inhibitor or overexpression of HMMR plasmid could reverse the inhibition in proliferation and glycolysis of LUAD cells induced by silencing of LINC00665. In summary, this study demonstrated that the LINC00665/let-7c-5p/HMMR regulatory axis promoted the tumorigenesis of LUAD by enhancing aerobic glycolysis, suggesting that this regulatory axis was an effective target for inhibiting LUAD progression and providing theoretical support for the development of new drugs for LUAD.

Supplementary Methods from Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA <i>let-7</i> Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells

Advances in Research of Let-7 in Cancer

Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part Via Microrna-107.

Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities.

H19/let‑7/Lin28 Cerna Network Mediates Autophagy Inhibiting Epithelial‑mesenchymal Transition in Breast Cancer.

Correction: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance

Lin28 Mediates Radiation Resistance Of Breast Cancer Cells Via Regulation Of Caspase, H2a.X And Let-7 Signaling

Lin28 Mediates Chemoresistance Through Inhibition Of Apoptotic Cell Death In Gastric Carcinoma Cells

Data from the &Lt;i>let-7&Lt;/i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China.

Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer

MicroRNA Let-7C-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments

Advances in Targeting the LIN28/Let-7 Pathway

Lin28 Mediates Cancer Chemotherapy Resistance Via Regulation of Mirna Signaling.

Long non-coding RNA OR3A4 is associated with poor prognosis of human non-small cell lung cancer and regulates cell proliferation <i>via</i> up-regulating SOX4 (vol 23, pg 6524, 2019)

Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy

Mir-203 Enhances Let-7 Biogenesis by Targeting LIN28B to Suppress Tumor Growth in Lung Cancer

Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell–mediated cytotoxicity and PD-1 checkpoint

LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis

The Let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells

LIN28B Suppresses Microrna Let-7B Expression to Promote CD44+/LIN28B+ Human Pancreatic Cancer Stem Cell Proliferation and Invasion.